Matinas BioPharma | Investor Presentation Deck | 29 slides · page 24 of 29
The slide compares LNC formulations against IMQ-only and IL-17A antibody controls.
Pitch deck · appendix_data · analyze_data · dense density
Slide locked Sign in to view
Slide schematic 7/7
chart 5/5 paragraph 1/1 title 1/1
Components 7
bar-vertical bar-vertical bar-vertical line line paragraph headline
Tools 1
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.